glp-1 compounders FDA Intensifies Crackdown on Compounding Managing Compounded GLP-1 Medications: A
Description
Zubair, M., El Sharu, H., & Launico, M
It activates GLP-1 and GIP
2022 May 28 [cited 2023 Apr 3];14(6):1152
Yet protein purification and sequencing is a lengthy processbiochemical isolations from gut tissue also yield relatively small amounts of protein, making it difficult to study the function of these molecules in the lab
Given the risk of complications from uncontrolled diabetes, such as the increased risk of wound infections from hyperglycemia, it would be in a patients best interest to continue these medications in the perioperative setting
